This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
Charles Schwab Corp. in 2017 - Teaching note
Siegel, R; Makinen, JTeaching Note SGSB-SM282TN-EStrategyBy almost any measure, Charles Schwab Corp. appeared to be killing it in 2017. The wealth management, banking, custody and brokerage firm’s stock was trading near its all-time high. It was posting unprecedented levels of new client accounts, net new client assets, revenues and profits and had a record $3.12 trillion in client assets under management. Schwab was taking customers and assets from old-line wire houses like Morgan Stanley, while fendi...Starting at €0.00
-
Charles Schwab Corp. in 2017
Siegel, R; Makinen, JCase SGSB-SM282-EStrategyBy almost any measure, Charles Schwab Corp. appeared to be killing it in 2017. The wealth management, banking, custody and brokerage firm’s stock was trading near its all-time high. It was posting unprecedented levels of new client accounts, net new client assets, revenues and profits and had a record $3.12 trillion in client assets under management. Schwab was taking customers and assets from old-line wire houses like Morgan Stanley, while fendi...Starting at €8.20
-
Acibadem Healthcare Group
Herzlinger, Regina E.; Cekin, Esel; Kindred, Natalie; Yucaoglu, GamzeCase HBS-315120-EThis case focuses on Ac badem Healthcare Group's, Turkey's only premium nationwide hospital network, potential expansion strategies after it was acquired by International Healthcare Holdings Berhad (IHH) in 2011, the world's second-largest publicly listed health care group and a private hospital leader in Singapore and Malaysia. By providing perspectives on both Ac badem and IHH-Parkway-Pantai's operational models, growth aspirations, collabora...Starting at €8.20
-
Turkey and Russia: Dangerous Liaisons
Abdelal, Rawi; Cekin, Esel; Kuzucu, Eren; Yucaoglu, GamzeCase HBS-717035-EEconomicswhether in light of the existing uncertainties companies operating in both countries can resume their investments and commercial activities, or should decisions be put on hold? What is the best strategy during such turbulent times? Can companies bet that a reunion would last?Starting at €8.20
-
Invitrogen/Life Technologies (B)
Burgelman, R; Siegel, R; Lee, RCase SGSB-SM209B-EStrategyOn June 12, 2008, Invitrogen and Applied Biosystems announced plans to merge. The combined company was to be renamed Life Technologies (NASDAQ: LIFE). Invitrogen offered to acquire Applied Biosystems for $6.7 billion in cash and stock. AB shareholders would receive $38 per share in cash and stock, representing a 17 percent premium over the share’s closing price on Wednesday, June 11, 2008.Starting at €5.74
-
Flibe Energy: Pursuing a Safe, Affordable, and Sustainable Energy Future
Burgelman, R; Siegel, R; Nolan, SCase SGSB-SM208-EStrategyFlibe Energy is a startup in the nuclear power space seeking to find a safe way to enable nuclear energy using a technology previously dismissed by the US government since it could not be used for making material for nuclear weapons. The founders believe they have found a way to create safe, clean energy using a proven but forgotten technology. The challenges are steep, however, as proof of the technology will require hundreds of millions of doll...Starting at €8.20
-
Waste Management's Organic Growth Group
Burgelman, R; Siegel, R; Uribe, TCase SGSB-SM210-EStrategyIt was 2005 and David Steiner, CEO of Waste Management (WM), had just received a report from an internal advisory panel created some months before to assess the future of the waste management industry and propose how the company’s strategy should be adapted. The core of this report was the recommendation to create a special unit within the company, chartered with the central purpose of identifying ways to extract value from waste through new and ...Starting at €8.20
-
Minted in 2014: Scaling and Scoping a Crowdsourcing Design Business
Burgelman, R; Siegel, R; Kuyel, SCase SGSB-E530-EEntrepreneurshipMariam Naficy (Minted CEO) and Melissa Kim (Minted COO) have grown the company to become a leader in the online printed cards, independent design and art market segments. As the business has continued to scale they wrestle with simultaneously growing their existing business while also looking at expanding into new markets, all the while keeping their existing customer base engaged. The case highlights the difficult decisions management faces in d...Starting at €8.20
-
Minted in 2017: Designing a Profitable Brand
Siegel, R; Kuyel, SCase SGSB-SM275-EStrategyMariam Naficy (Minted CEO) and Melissa Kim (Minted COO) have grown the company to become a leader in the online printed cards, independent design and art market segments. As the business has continued to scale they wrestle with simultaneously growing their existing business while also looking at expanding into new markets, all the while keeping their existing customer base engaged. The case highlights the difficult decisions management faces in d...Starting at €8.20
-
iyzico: Fundraising in Emerging Markets (B)
Di Maggio, Marco; Yucaoglu, GamzeCase HBS-219065-EFinanceThe case opens in July 2016 as Barbaros Ozbugutu, co-founder and CEO of the Istanbul-based payment technology start-up iyzico, contemplates the pros and cons of the different term sheets the company has received for its Series C round. The case then informs the reader about some changes in circumstances that affected the terms of the shortlisted offers. At the end, the case poses this question: Being faced with worsening terms in a volatile envir...Starting at €5.74